Search for: "Mylan Pharmaceuticals v. FDA"
Results 81 - 100
of 233
Sorted by Relevance
|
Sort by Date
7 May 2012, 5:00 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
23 Jun 2010, 10:28 pm
Mylan Inc. et al. [read post]
19 Oct 2017, 10:29 am
In Allergan, Inc. v. [read post]
19 Oct 2017, 10:29 am
In Allergan, Inc. v. [read post]
20 Oct 2010, 1:20 pm
Mylan, Inc., 2010 WL 2008797, slip op. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
28 Aug 2013, 10:31 am
By Dennis Crouch Leo Pharmaceutical Products, Ltd. v. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing… [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs)… [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
Obama Administration Urges Supreme Court to Grant Certiorari in Case on Orange Book Patent Use Codes
30 May 2011, 9:49 pm
PIRG; the Generic Pharmaceutical Association (GPhA); Mylan; and Teva. [read post]
11 May 2011, 4:54 am
Highlights this week included: US: Federal Trade Commission issues report on reverse settlement agreements in FY2010 (Patent Docs) (Orange Book Blog) (FDA Law Blog) US: Billups-Rothenberg v. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix… [read post]
7 Sep 2010, 6:10 pm
biuras, Amgen Europe BV (The SPC Blog) Aricept (Donepezil) – US: District Court denies Apotex declaratory judgment motion on generic Aricept; does not accept ‘prompt launch’ and ‘indefinite delay’ jurisdiction theories (FDA Law Blog) Chantix (Varenicline) – US: Pfizer files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (AboutLawsuits.com) Copaxone (Glatiramer) – US: Court denies Sandoz/Momenta’s… [read post]
28 Jun 2007, 10:16 am
Citizen Action v. [read post]
8 Dec 2020, 1:00 pm
[1] Complaint at 1-2, Merck Sharp & Dohme Corp. v. [read post]
31 Oct 2011, 6:46 am
They are also now big, big litigation.You might think that last week's decision in Hughes v Mylan, Inc., 2011 U.S. [read post]
29 Jun 2011, 3:34 am
Demahy (FDA Law Blog) Modafinil – UK: EWHC (Pat): Patents not infringed but obvious – Cephalon, Inc v Orchid Europe (EPLAW) (IPKat) Paracetamol – Nigerian court slaps huge damages on GSK in Panadol dispute (Afro-IP) Silenor (Doxepin) – US: Somaxon files patent infringement suit against Mylan for trying to market generic Silenor (GenericsWeb) Suprane (Desfluorane) – US: FDA grants Baxter’s petition for second 30-month stay… [read post]
